logo
Select company
Select metric
14.73%Cash to Assets Ratio
VS
Market
67
Sector
35
Industry
48
History
25
$ 13.58Close
$ 8.25 - $ 29.25 52-Week Range
Ticker Information

Ticker

POAI

Company Name

PREDICTIVE ONCOLOGY INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

PREDICTIVE ONCOLOGY INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

POAI - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 3.44M$ 506.08K14.73%
3/31/2025$ 5.87M$ 3.09M52.62%
12/31/2024$ 4.97M$ 734.67K14.77%
9/30/2024$ 7.5M$ 3.08M41.06%
6/30/2024$ 10.59M$ 5.33M50.36%
3/31/2024$ 10.6M$ 5.2M49.03%
12/31/2023$ 14.42M$ 8.73M60.54%
9/30/2023$ 18.17M$ 11.92M65.59%
6/30/2023$ 20.97M$ 14.76M70.41%
3/31/2023$ 25.06M$ 18.6M74.21%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PREDICTIVE ONCOLOGY INC's latest trailing twelve months (TTM) Cash to Assets stands at 9.83%.
  • Over the past 5 years, PREDICTIVE ONCOLOGY INC's average Cash to Assets has been 55.23%.
  • The median Cash to Assets for PREDICTIVE ONCOLOGY INC during this period was 63.56%
  • PREDICTIVE ONCOLOGY INC reached its highest Cash to Assets over the past 5 years at 85.77%.
  • The lowest Cash to Assets recorded by PREDICTIVE ONCOLOGY INC in the same timeframe 5.19%

PREDICTIVE ONCOLOGY INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
PAVM : PAVMED INC 9.12%CODX : CO-DIAGNOSTICS INC 23.92%APRE : APREA THERAPEUTICS INC 95.74%LUCY : INNOVATIVE EYEWEAR INC 63.9%LYRA : LYRA THERAPEUTICS INC 60.44%STSS : SHARPS TECHNOLOGY INC 48.71%VYNE : VYNE THERAPEUTICS INC 49.3%SXTP : 60 DEGREES PHARMACEUTICALS INC 47.03%BRTX : BIORESTORATIVE THERAPIES INC 18.26%SPRB : SPRUCE BIOSCIENCES INC 75.1%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PREDICTIVE ONCOLOGY INC is calculated as follows: CashnEq [ $ 2.47M ] / Assets [ $ 25.16M ]
(=) Cash to Assets [ 9.83% ]

POAI - Cash to Assets Ratio, Last 5 years

5.19%

Minimum

Dec 31, 2020

85.77%

Maximum

Dec 31, 2022

55.23%

Average

63.56%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%